58 studies found for:    BUTYRYLCHOLINESTERASE
Show Display Options
Rank Status Study
1 Completed Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects
Condition: Butyrylcholinesterase Deficiency
Intervention: Drug: AZD8848
2 Not yet recruiting Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine
3 Completed A Study of Plasma-Derived Human Butyrylcholinesterase Administered Intramuscularly
Condition: Healthy
Interventions: Drug: Human butyrylcholinesterase (HuBChE) derived from human plasma;   Drug: Placebo: Normal saline
4 Completed Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered Intravenously
Conditions: Chemical Terrorism;   Chemical Warfare
Interventions: Drug: Human Butyrylcholinesterase (HuBChE) derived from human plasma;   Drug: Placebo: Normal saline
5 Not yet recruiting Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Rivastigmine
6 Completed Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults
Conditions: Mental Health;   Geriatrics
Interventions: Drug: donepezil;   Drug: Placebo (cornstarch)
7 Completed Estimation of Functional Liver Reserve Using Cholinesterases
Conditions: Hepatocellular Carcinoma;   Cirrhosis;   Liver Neoplasm;   Liver Disease
Intervention:
8 Recruiting Relevance of the Peripheral Cholinesterase-activity on Neurocognitive Dysfunctions in Surgical Patients
Condition: Postoperative Delirium
Intervention:
9 Recruiting Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Cholinesterase Inhibitor;   Drug: Placebo
10 Completed Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment
Condition: Late Onset Alzheimer
Intervention:
11 Active, not recruiting Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
12 Recruiting A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease
Condition: Lewy Body Disease
Intervention: Drug: Cholinesterase Inhibitors (Rivastigmine, Aricept, Galantamine)
13 Completed Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: lecozotan SR (SRA-333)
14 Recruiting Bisnorcymserine in Healthy Adult Volunteers
Condition: Alzheimer's Disease
Intervention: Drug: BNC
15 Completed To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
Condition: Alzheimer's Disease
Intervention: Drug: Atorvastatin
16 Completed Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine, memantine
17 Recruiting Effect of Galantamine on Short-term Abstinence
Conditions: Treatment-seeking Smokers, Reporting Consumption of at Least 10 Cigarettes;   Per Day for at Least the Past 6 Months
Intervention: Drug: Galantamine Hydrobromide-ER
18 Recruiting Treatment of Residual Amblyopia With Donepezil
Condition: Amblyopia
Interventions: Drug: Donepezil;   Other: Patching
19 Recruiting Effect of Galantamine on Short-term Abstinence
Condition: Tobacco Use Disorder
Interventions: Drug: Galantamine;   Drug: Placebo
20 Completed Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: atomoxetine hydrochloride;   Drug: placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years